forty patients with refractory solid tumors or non-hodgkin 's lymphoma were treated with high-dose cyclophosphamide , thiotepa , and carmustine ( bcnu ) , followed by autologous stem cell rescue , in a phase i dose escalation study .
C0024305
non-hodgkin 's lymphoma
C0007257
bcnu